Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-16-000769
Filing Date
2016-01-26
Accepted
2016-01-26 12:15:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 Bellicum_Pharmaceuticals_Inc.HTM SC 13G 39757
  Complete submission text file 0000019617-16-000769.txt   41695
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Subject) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88493 | Film No.: 161360635
SIC: 2834 Pharmaceutical Preparations